Bonum Therapeutics

0 followers


Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.

Employees

11-50

Links

Org chart

John Mulligan, Ph.D.
Founder and CEO

John Mulligan, Ph.D.

Collapse
Cindy Lai Yee
Vice President Of Preclinical Development
David Bienvenue
Senior Director, Protein Sciences
Justin Killebrew
Vice President, Biology